» Articles » PMID: 27865002

Gold(I) NHC Complexes: Antiproliferative Activity, Cellular Uptake, Inhibition of Mammalian and Bacterial Thioredoxin Reductases, and Gram-Positive Directed Antibacterial Effects

Overview
Journal Chemistry
Specialty Chemistry
Date 2016 Nov 20
PMID 27865002
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Gold complexes with N-heterocyclic carbene (NHC) ligands represent a promising class of metallodrugs for the treatment of cancer or infectious diseases. In this report, the synthesis and the biological evaluation of halogen-containing NHC-Au -Cl complexes are described. The complexes 1 and 5 a-5 f displayed good cytotoxic activity against tumor cells, and cellular uptake studies suggested that an intact Au-NHC fragment is essential for the accumulation of high amounts of both the metal and the NHC ligand. However, the bioavailability was negatively affected by serum components of the cell culture media and was influenced by likely transformations of the complex. One example (5 d) efficiently induced apoptosis in vincristine- and daunorubicin-resistant P-glycoprotein overexpressing Nalm-6 leukemia cells. Cellular uptake studies with this compound showed that both the wild-type and resistant Nalm-6 cells accumulated comparable amounts of gold, indicating that the gold drug was not excreted by P-glycoprotein or other efflux transporters. The effective inhibition of mammalian and bacterial thioredoxin reductases (TrxR) was confirmed for all of the gold complexes. Antibacterial screening of the gold complexes showed a particularly high activity against Gram-positive strains, reflecting their high dependence on an intact Trx/TrxR system. This result is of particular interest as the inhibition of bacterial TrxR represents a relatively little explored mechanism of new anti-infectives.

Citing Articles

Quinizarin Gold(I) N-Heterocyclic Carbene Complexes with Synergistic Activity Against Anthracycline-Resistant Leukaemia Cells: Synthesis and Biological Activity Studies.

Steinbrueck A, Reback M, Rumancev C, Siegmund D, Garrevoet J, Falkenberg G Chemistry. 2025; 31(11):e202404147.

PMID: 39757433 PMC: 11840658. DOI: 10.1002/chem.202404147.


Exploring the Thioredoxin System as a Therapeutic Target in Cancer: Mechanisms and Implications.

Seitz R, Tumen D, Kunst C, Heumann P, Schmid S, Kandulski A Antioxidants (Basel). 2024; 13(9).

PMID: 39334737 PMC: 11428833. DOI: 10.3390/antiox13091078.


A New Class of Gold(I) NHC Complexes with Proapoptotic and Resensitizing Properties towards Multidrug Resistant Leukemia Cells Overexpressing BCL-2.

Bannwart F, Richter L, Stifel S, Rueter J, Lode H, Correia J J Med Chem. 2024; 67(17):15494-15508.

PMID: 39196554 PMC: 11403678. DOI: 10.1021/acs.jmedchem.4c01117.


Gold(i) and gold(iii) carbene complexes from the marine betaine norzooanemonin: inhibition of thioredoxin reductase, antiproliferative and antimicrobial activity.

Mahdavi S, Bockfeld D, Esarev I, Lippmann P, Frank R, Bronstrup M RSC Med Chem. 2024; .

PMID: 39185451 PMC: 11342128. DOI: 10.1039/d4md00358f.


Metal complexes of backbone-halogenated imidazol-2-ylidenes.

Bugarin A, Patil S, Tran R, Marichev K Inorganica Chim Acta. 2024; 572.

PMID: 39156221 PMC: 11326507. DOI: 10.1016/j.ica.2024.122263.